# Carboplatin Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current, To Be Discontinued - FDA package records: 35 - Latest FDA row update: 08/18/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Accord Healthcare Inc. — Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12) — FDA availability: Unavailable — updated: 08/17/2026 - Accord Healthcare Inc. — Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31) — FDA availability: Unavailable — updated: 08/17/2026 - Accord Healthcare Inc. — Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33) — FDA availability: Unavailable — updated: 08/17/2026 - Accord Healthcare Inc. — Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34) — FDA availability: Unavailable — updated: 08/17/2026 - Avyxa Pharma, LLC — Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50) — FDA availability: Available — updated: 08/04/2026 - Avyxa Pharma, LLC — Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08) — FDA availability: Available — updated: 08/04/2026 - Eugia US LLC — Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01) — FDA availability: Unavailable — updated: 08/06/2026 - Eugia US LLC — Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01) — FDA availability: Available — updated: 08/06/2026 - Fresenius Kabi USA, LLC — Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60) — FDA availability: Unavailable — updated: 08/04/2026 - Gland Pharma Limited — Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01) — FDA availability: Limited Availability — updated: 07/22/2026 - Gland Pharma Limited — Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01) — FDA availability: Limited Availability — updated: 07/22/2026 - Gland Pharma Limited — Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01) — FDA availability: Unavailable — updated: 07/22/2026 - Gland Pharma Limited — Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01) — FDA availability: Limited Availability — updated: 07/22/2026 - Hospira, Inc., a Pfizer Company — Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05) — FDA availability: Unavailable — updated: 08/07/2026 - Ingenus Pharmaceuticals LLC — Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45) — FDA availability: Not stated — updated: 02/20/2026 - Ingenus Pharmaceuticals LLC — Carboplatin, Injection, 600 mg/60 mL (NDC 50742-448-60) — FDA availability: Not stated — updated: 02/20/2026 - Teva Pharmaceuticals USA, Inc. — Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01) — FDA availability: Limited Availability — updated: 08/17/2026 - Teva Pharmaceuticals USA, Inc. — Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01) — FDA availability: Unavailable — updated: 08/17/2026 - Teva Pharmaceuticals USA, Inc. — Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01) — FDA availability: Unavailable — updated: 08/17/2026 - Teva Pharmaceuticals USA, Inc. — Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01) — FDA availability: Unavailable — updated: 08/17/2026 - Teyro Labs — Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3) — FDA availability: Unavailable — updated: 08/18/2026 - Teyro Labs — Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3) — FDA availability: Not stated — updated: 06/01/2026 - Teyro Labs — Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6) — FDA availability: Unavailable — updated: 08/18/2026 - Teyro Labs — Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6) — FDA availability: Not stated — updated: 06/01/2026 - Teyro Labs — Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1) — FDA availability: Unavailable — updated: 08/18/2026 - Teyro Labs — Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1) — FDA availability: Not stated — updated: 06/01/2026 - Teyro Labs — Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7) — FDA availability: Unavailable — updated: 08/18/2026 - Teyro Labs — Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7) — FDA availability: Not stated — updated: 06/01/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/carboplatin-injection) - [JSON record](https://citefacts.com/shortages/carboplatin-injection.json)